Vertebral osteomyelitis and epidural abscess in a patient receiving enfuvirtide.
Portilla
J
J
Unit of Infectious Diseases, Hospital General Universitario de Alicante, Maestro Alonso 109, 03010 Alicante, Spain.
Boix
V
V
Merino
E
E
Reus
S
S
Seguí
J M
JM
Lopez-Azkarreta
I
I
D000328:Adult; D000900:Anti-Bacterial Agents; D004359:Drug Therapy, Combination / Q000627:therapeutic use; D000077560:Enfuvirtide; D020802:Epidural Abscess / Q000139:chemically induced* / Q000175:diagnosis / Q000188:drug therapy / Q000276:immunology; D005500:Follow-Up Studies; D015700:HIV Envelope Protein gp41 / Q000008:administration & dosage / Q000009:adverse effects*; D015658:HIV Infections / Q000175:diagnosis / Q000188:drug therapy*; D018451:Homosexuality, Male; D006801:Humans; D016867:Immunocompromised Host / Q000187:drug effects*; D007279:Injections, Subcutaneous; D008297:Male; D010446:Peptide Fragments / Q000008:administration & dosage / Q000009:adverse effects*; D018570:Risk Assessment; D013166:Spondylitis / Q000139:chemically induced* / Q000175:diagnosis / Q000188:drug therapy / Q000276:immunology; D013904:Thoracic Vertebrae; D016896:Treatment Outcome
D000900:Anti-Bacterial Agents; D015700:HIV Envelope Protein gp41; D010446:Peptide Fragments; D000077560:Enfuvirtide